Federal Register / Vol. 71, No. 19 / Monday, January 30, 2006 / Notices 4923 

is essential to the mission of the NIH [42 

U.S.C. 241 and 282(b)(1)]. In December 

2003, the House Energy and Commerce 

Committee raised concerns about 

potential conflicts of interest at NIH. In 

response to these concerns, the NIH 

Director, Dr. Elias Zerhouni, ordered an 

internal investigation into consulting 

agreements at NIH and in June 2004 

proposed changes to the agency’s 

conflict-of-interest policies. Effective 

February 3, 2005, the new regulations (5 

CFR Parts 5501 and 5502, 

‘‘Supplemental Standards of Ethical 

Conduct and Financial Disclosure 

Requirements for Employees of the 

Department of Health and Human 

Services,’’ FR Vol. 70, No. 22, Thursday, 

February 3, 2005, 5543–5565, and Vol. 

70, No. 168, Wednesday, August 31, 

2005, 51559–51574) apply to all NIH 

employees and, among other things, 

place limits on certain financial 

holdings of the most senior NIH 

employees, their spouses, and minor 

children and on certain outside 

activities in which NIH staff may 

engage. Gauging both the immediate and 

longer term impact of these new rules is 

crucial to NIH’s ability to develop and 

maintain a world-class staff. This 

project will produce data that will help 

NIH and HHS leaders determine the 

impact of the regulations and how to 

minimize the effect of the regulations on 

NIH’s ability to recruit and retain staff. 

NIH intends to survey potential 

applicants for NIH employment from 

scientific organizations from which NIH 

has traditionally drawn leading 

scientific personnel, and those senior 

scientists and administrators who have 

voluntarily left NIH since February 

2005. This will allow NIH to determine 

whether the regulations impact 

individuals’ attitudes about 

employment at NIH and the likelihood 

of their joining and/or leaving the 

agency. 

Frequency of Response: One time. 

Affected Public: Individuals and 

households. Type of Respondent: Highly 

trained and qualified scientists engaged 

in medicine and life sciences research. 

The annual reporting burden is as 

follows: Estimated Number of 

Respondents: 500; Estimated Number of 

Responses per Respondent: One; 

Average Burden Hours Per Response: 15 

minutes; and Estimated Total Annual 

Burden Hours Requested: 117 hours. 

The annualized cost to respondents is 

estimated at $3,850. There are no 

Capital Costs, Operating Costs, or 

Maintenance Costs to report. 

Request for Comments 

Written comments and/or suggestions 

from the public and affected agencies 

should address one or more of the 

following points: (1) Evaluate whether 

the proposed collection of information 

is necessary for the proper performance 

of the function of the agency, including 

whether the information will have 

practical utility; (2) Evaluate the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(3) (enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Minimize the burden 

of the collection of information on those 

who are to respond, including the use 

of appropriate automated electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Comments Due Date 

Comments regarding this information 

collection are best assured of having 

their full effect if received within 60 

days of the date of this publication. 

For More Information or to Direct 

Comments: To submit comments, to 

request more information on the 

proposed project, or to obtain a copy of 

the data collection plans and 

instruments, contact Mr. Richard M. 

Taffet, Acting Director, Client Services 

Division; Office of Human Resources, 

Office of the Director, National 

Institutes of Health, Room 2–D234, East 

Jefferson Street, Bethesda, MD 20892–

8502, or call the non-toll-free number 

(301) 402–6627, or e-mail your 

comments or request, including your 

address, to: taffetr@mail.nih.gov. 

Dated: January 23, 2006. 

Raynard S. Kington, 

Deputy Director, National Institutes of Health. 

[FR Doc. 06–845 Filed 1–27–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, SBIR Topic 

208 (Phase I) ‘‘Targetry Systems for 

Production of Research Radionucleides’’. 

Date: February 23, 2006. 

Time: 12 p.m. to 4 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: C. Michael Kerwin, PhD, 

MPH, Scientific Review Administrator, 

Special Review and Logistics Branch, 

Division of Extramural Activities, National 

Cancer Institute, National Institutes of 

Health, 6116 Executive Boulevard, Room 

8057, MSC 8329, Bethesda, MD 20892–8329, 

301–496–7421, kerwinm@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: January 23, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–846 Filed 1–27–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, SBIR Topic 

207 (Phase I) ‘‘Synthesis Modules for 

Radiopharmaceutical Production’’. 


cprice-sewell on PROD1PC66 with NOTICES